IndraLab

Statements

Alpha-hERG1-MoAb activates KCNH2. 1 / 1

| 1

reach

"The possibility to exploit the alpha-hERG1-MoAb to target hERG1 in vivo could have an immediate clinical fallout for the diagnosis and clinical follow-up of PDAC."

25719829

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Alpha-hERG1-MoAb activates KCNH2. 1 / 1

INDRA sources:

Databases

Reading